Skip to main content
. Author manuscript; available in PMC: 2014 Jan 12.
Published in final edited form as: Pediatr Res. 2012 Jul 20;72(4):375–383. doi: 10.1038/pr.2012.96

Figure 5.

Figure 5

Plasma cytokine concentrations. Open bars are baseline and solid bars are 4 h values. (a). Plasma IL-8 following lucinactant or poractant alfa treatment was lower (*P < 0.01) than in negative controls and those treated with lucinactant had lower plasma IL-8 levels than those treated with beractant (**P < 0.01). (b) Plasma IL-6 was lower (*P < 0.01) in all SRT groups as compared with in negative controls. In addition, plasma IL-6 (b) in those treated with either lucinactant or poractant alfa was lower (**P < 0.05) than in those treated with beractant. IL, interleukin; SRT, surfactant replacement therapy.